ASML.AS (ASML.AS)

$455.5B
Market Cap
47.5
P/E Ratio
1.43
Beta
0.89%
Dividend Yield
Piotroski 8/9Altman Z 10.9 SafeBeneish M -2.84 CleanROIC−WACC +21.1%

Quantitative Summary

Deterministic

Financial health metrics are strong: Piotroski 8/9, Altman Z 10.9 (above 3.0 safe zone threshold).

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The company exhibits exceptional fundamental quality, characterized by a robust ROIC-WACC spread of 21.1%, indicating highly efficient capital allocation relative to its cost of equity. This superior return is driven primarily by expansive net margins at 29.4% rather than operational leverage or balance sheet risk; the DuPont decomposition reveals that while asset turnover sits modestly at 0.65x and financial leverage provides a multiplier of only 2.58x, the margin profile dominates the 49.0% ROE generation. Integrity metrics further reinforce this view, with a Piotroski F-Score of 8/9 signaling strong financial health, an Altman Z-Score of 10.9 suggesting negligible bankruptcy risk, and a negative Beneish M-Score of -2.84 that points to low earnings manipulation probability.

Despite these operational strengths, the current valuation presents a significant premium, trading at a P/E ratio of 47.5x which must be weighed against historical norms and sector averages not provided in the dataset. The market appears to price in substantial future growth, as reflected by the reported revenue expansion of 15.6% year-over-year; however, this multiple implies that current earnings are fully valued or exceeded based on a DCF fair value calculation of $667. Any deviation from the implied growth assumptions embedded within such a high multiple could materially compress valuation multiples, creating potential downside volatility if execution falters relative to these aggressive expectations.

No specific risk factor deltas, insider trading activity, or Fama-French alpha data were provided in the input to refine the risk-reward profile further. Consequently, the investment thesis rests entirely on whether the company can sustain its margin expansion and revenue growth trajectory to justify the current premium valuation without relying on leverage increases or significant turnover improvements.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →11.5%13.5%15.5%
2%$767$624$525
3%$836$667$554
4%$923$719$587

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=13.5%, terminal growth 3%. Fair value $667 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

8/9
Piotroski F-Score
Strong — high operational efficiency and profitability signals
10.9
Altman Z-Score
Safe Zone — above 3.0 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-2.84
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

52.8%
Gross Margin
29.4%
Net Margin
34.6%
ROIC
13.5%
WACC
ROIC − WACC Spread: +21.1%— Positive value creation spread.
+15.6%
Revenue Growth (YoY)
+26.9%
Earnings Growth (YoY)
11.0B
Free Cash Flow
23%
FCF Payout Ratio

✅ Conservative payout — room for dividend increases.

DuPont Analysis — ROE Decomposition

Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.

29.4%
Net Profit Margin
NI ÷ Revenue
×
0.65x
Asset Turnover
Revenue ÷ Assets
×
2.58x
Equity Multiplier
Assets ÷ Equity
=
49.0%
Return on Equity
✅ ROE driven primarily by strong profit margins — a sign of pricing power.

Balance Sheet Health

1.58x
Debt / Equity
1.26x
Current Ratio
97.4x
Interest Coverage
-0.8x
Net Debt / EBITDA
2.48%
FCF Yield
12.6B
EBITDA

Earnings Surprise History

Q4
✓ Beat
Est: $5.79
Act: $6.00
+3.7%
Q3
✓ Beat
Est: $5.25
Act: $5.90
+12.4%
Q2
✓ Beat
Est: $5.37
Act: $5.49
+2.1%
Q1
✗ Miss
Est: $7.55
Act: $7.34
-2.7%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

31.2
Forward P/E
PEG Ratio
23.06
Price/Book
702729
Avg Volume
$1312.80
52W High
$508.40
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$673M
Tracked Passive Exposure
2
ETFs Holding ASML.AS
6.94%
Avg Weight in ETFs
$10B
Total ETF AUM

When investors buy or sell ETFs like EZU or DWM, the fund manager is mechanically forced to buy or sell ASML.AS shares regardless of ASML.AS's individual fundamentals. We estimate $673M of passive capital is structurally linked to ASML.AS through 2 tracked ETFs. Passive flows have a limited but growing influence on ASML.AS's daily trading dynamics.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 2 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in ASML.AS to visualize passive redemption contagion across ETFs and collateral stocks.

ASML.AS Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
ASML.ASEpicenterEZUETFDWMETFSIE.DEMed RiskTTE.PAHigh RiskSAN.MCHigh RiskSAP.DELow RiskALV.DEHigh Risk
ASML.AS Price Drop (%)0

If ASML.AS (ASML.AS) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Siemens AG (SIE.DE) as the most exposed collateral stock, sharing 1 ETFs with ASML.AS. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 2 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

ASML.AS Ownership Dynamics

Ticker
ASML.AS

ETFs with Highest ASML.AS Exposure

Float lock-up computed from 0 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

ASML.AS Capital Efficiency

How efficiently does ASML.AS convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$11.0B
EBITDA
$12.6B
FCF Conversion
88%
Reinvestment Rate
12%
88% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
34.6%
ROIC − WACC Spread
21.1%

ASML.AS converts 88% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag. The positive ROIC-WACC spread of 21.1% confirms that reinvested capital creates shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Compare ASML.AS to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.